CN103719987A - Spirulina health care drink - Google Patents
Spirulina health care drink Download PDFInfo
- Publication number
- CN103719987A CN103719987A CN201210387939.9A CN201210387939A CN103719987A CN 103719987 A CN103719987 A CN 103719987A CN 201210387939 A CN201210387939 A CN 201210387939A CN 103719987 A CN103719987 A CN 103719987A
- Authority
- CN
- China
- Prior art keywords
- spirulina
- people
- beverage
- water
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 52
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims abstract description 52
- 229940082787 spirulina Drugs 0.000 title claims abstract description 52
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 7
- -1 sucrose ester Chemical class 0.000 claims abstract description 5
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 4
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930006000 Sucrose Natural products 0.000 claims abstract description 4
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 4
- 239000003651 drinking water Substances 0.000 claims abstract description 4
- 235000020188 drinking water Nutrition 0.000 claims abstract description 4
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 4
- 239000004310 lactic acid Substances 0.000 claims abstract description 4
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 4
- 239000005720 sucrose Substances 0.000 claims abstract description 4
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 4
- 239000011718 vitamin C Substances 0.000 claims abstract description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 4
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 4
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 4
- 235000013361 beverage Nutrition 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 6
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000001976 enzyme digestion Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000019629 palatability Nutrition 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009849 vacuum degassing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
- 235000013734 beta-carotene Nutrition 0.000 abstract 1
- 239000011648 beta-carotene Substances 0.000 abstract 1
- 229960002747 betacarotene Drugs 0.000 abstract 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 108010053210 Phycocyanin Proteins 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 241000252983 Caecum Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002497 iodine compounds Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 231100000417 nephrotoxicity Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 208000017983 photosensitivity disease Diseases 0.000 description 2
- 231100000434 photosensitization Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- NNMALANKTSRILL-ZUTFDUMMSA-N 3-[(2z,5z)-2-[[3-(2-carboxyethyl)-5-[(z)-[(3z,4r)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid Chemical compound O=C1C(CC)=C(C)C(\C=C/2C(=C(CCC(O)=O)C(=C/C3=C(C(C)=C(\C=C/4\C(\[C@@H](C)C(=O)N\4)=C/C)N3)CCC(O)=O)/N\2)C)=N1 NNMALANKTSRILL-ZUTFDUMMSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- INPDFIMLLXXDOQ-UHFFFAOYSA-N Phycocyanobilin Natural products CCC1=C(C)C(=CC2=NC(=C/c3[nH]c(C=C/4C(C(C(N4)=O)C)=CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O INPDFIMLLXXDOQ-UHFFFAOYSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 229940089536 indocin Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010072011 phycocyanobilin Proteins 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to the drink field, in particular to a spirulina health care drink, which is prepared by processing of: 0.2-0.3% of spirulina, 9-12% of white granulated sugar, 0.08% of citric acid, 0.02% of lactic acid, 0.02% of vitamin C, 0.02% of zinc gluconate, 0.06% of sucrose ester, 0.02% of ethylenediamine tetraacetic acid disodium salt, 0.03% of beta-carotene, 0.06% of lemon essence, and the balance drinking water. The obtained product is a nourishing drink that has the physiological function of adjusting the human body, can enhance immunity, and is easy to digest.
Description
Technical field
The present invention relates to field of beverage, refer in particular to a kind of spirulina health-care beverage.
Background technology
At present, often go on business, busy clerical workforce, fat-reducing personage or large, the physical overdraw of stress, hypoimmunity, anaemia, nutrition condition is bad, erratic personage is a lot of for diet, for these crowds, the technical problem to be solved in the present invention is to provide a kind of physiological function that can regulate human body that has, strengthen immunity, be easy to again the tonic beverage of digestion.
Summary of the invention
The object of the invention is to, a kind of spirulina health-care beverage is provided, adopt following technical scheme (with 1000 liters of finished products, raw materials by weight meter): a, spirulina 0.2-0.3%, white granulated sugar 9-12%, citric acid 0.08%, lactic acid 0.02%, vitamin C 0.02%, zinc gluconate 0.02%, sucrose ester 0.06%, disodium ethylene diamine tetraacetate 0.02%, β-carrotene 0.03%, lemon extract 0.06%, drinking water are standby; B, technological process: 1. spirulina leaching liquor is prepared in pretreatment; Spirulina is added to water 60kg, and mixing its pH of rear adjustment thoroughly is 11 left and right, separately prepares 2. 5% enzyme liquid, add people 2.5kg, and control temperature is 48-50 ℃, carries out the enzyme digestion reaction of 6-7h.Can add subsequently the color stabilizers such as disodium ethylene diamine tetraacetate to protect look, then spirulina liquid be entered to supercentrifuge, under 3500 revs/min of conditions, operate 15-20 minute, obtain its clear liquid; 2. allotment is first warded off white sand and is added l times of warm water and dissolve, then adds the solution of other raw materials of people, mixes, adds spirulina liquid again, starts agitator and stirs, and adds subsequently water and is settled to 1000 liters; 3. homogeneous, degassed by mixed liquor people high pressure homogenizer homogeneous, homogenization pressure is 25-3OMPa, removes the air in beverage immediately with vacuum degassing machine; 4. filling, sterilization is heated to 60-65 ℃ by beverage with plate type heat exchanger, is filled into while hot bottle, then in people's hot water, sterilization 15-20 minute at 100 ℃ of temperature, after cooling green transparent, sweet and sour palatability, the spirulina health-care beverage of tool taste of fruit.
The invention has the beneficial effects as follows: by the joint of described formula and production technology, what obtain has a physiological function that can regulate human body, strengthens immunity, is easy to again the tonic beverage of digestion.
The pharmacological action of spirulina:
1, Antiradiation injury effect: the forward and backward oral spirulina of mouse of giving of radiating irradiation, all can improve mouse survival rate, effective dose is every 3.75-15mg (156-625mg/kg body weight, takes number of times 2-5 time).Spirulina prevention administration 3 times; after 7.5Gy irradiates the 9th day; observation to the responsive organ of exposure animal shows; spirulina can make to irradiate the thymic weight, marrow DNA content of mouse higher than control group; this shows that spirulina has protective effect to immune organ and hematopoietic tissue, and this may be one of mechanism of spirulina Antiradiation injury effect.
2, antibacterial action: blunt top spirulina has bacteriostasis to gram positive bacteria, the strongest containing the ethanol extract bacteriostatic activity of the blunt top spirulina of lipid and triterpene compound, containing the extract of sterol, also there is bacteriostasis, but a little less than effect.Blunt top spirulina is to gram-negative bacteria unrestraint effect.
3, antitumaous effect: spirulina is to a short-term shot and long-term multiple injection 1, the NIH mouse of 2-Dimethylhydrazine induction and standard deviation rat large intestine sex change crypts be formed with inhibitory action.Spirulina polysaccharide has the inhibiting rate showing to ascites hepatoma cells in body, treatment group is 54.0%, prevents and treats group and reaches 91.4%, and the inhibitory action of cancer cell DNA, RNA and protein is all strengthened with extending action time.
4, photosensitization: with process the murine myeloma cell of cultivating containing the phycocyanin (phycocyanobilin) of 0.25mg/ml, then through 514nm laser irradiation 300J/cm2, find cancer cell survival rate only 15%; And adopting merely laser irradiation or phycocyanin to process, cell survival rate is 69% and 71%.Human Large Intestine Carcinoma Cells strain HR8348 uses respectively 100 μ g after cultivating, 50 μ g, the phycocyanin of the blunt top spirulina of 25 μ g is processed, the copper laser irradiation 12J/cm2 that is 630nm through light wave, with mtt assay, detect cultivation cancer cell survival rate and be respectively 22.2%, 37.6% and 89.7%, show good dosage effect.To sarcoma S180 mouse, give respectively after phycocyanin injection 2mg or oral 20mg, through copper laser irradiation knurl body after 15 days, be efficiently respectively 50% and 53%, to compare with control group, tool is showing difference.Internal and external test confirms that phycocyanin truly has photosensitization, and without toxicity, is a kind of desirable sensitising agent.
5, to immune effect: spirulina polysaccharide can make the serum hemolysin of mouse improve 39.5%-98.0%, the phagocytic rate of peritoneal macrophage improves 32.5%-51.5%, phagocytic index improves 0.9-1.8 doubly, T lymphocyte number improves 46.8%-87.7%, spleen white pulp lymphocyte dense arrangement, macrophage showed increased in red pulp, acid α-naphthyl acetate esterase (ANAE) positive lymphocyte increases 7.3%-12.8%.
6, reduce cholesterol: by the male sex of 30 high cholesterols, slight high fat of blood, be divided into two groups, A group takes spirulina 4.2g every day, continues for 8 weeks, serum total cholesterol is down to 6.1mmol/L (233mg/dl) from 6.3mmol/L (244mg/dl) within 4 weeks, decreases by 4.5%.B group takes and just stopped in 4 weeks, and total serum cholesterol reduces, after return to initial level.LDL-C is showing to reduce and is reaching 6.1% within 4 weeks, the original people of elevated cholesterol, and the serum cholesterol range of decrease is larger.
7, improve biological effectiveness and the regulating anemia disease of iron: select purebred Wistar rat, by low iron dietary habit, copy hypoferric anemia model, with spirulina, recover test, with the positive control group of ferrous sulfate, with the negative control group of low iron feed, by spirulina content is ascending, be divided into 3 experimental group, content is respectively 1%, 8%, 15%.Result: test 2 groups and 3 groups of body weight of experiment higher than positive controls, test 1 group of body weight and positive controls approaching, positive controls body weight is higher than negative control group.Prompting pure iron deficiency can affect Growth in Rats, cause rat body weight and increases slowly, and spirulina has the effect that rat body weight increases of accelerating, and rat hypoferric anemia recovery effects is being shown.Another test of carrying out in Japan is, 8 young women longer-terms are limited to their diet, manifest time that long-term anemia--hemoglobin is lower than normal level, then after regular meal, eat 4g spirulina, take after 80 days, hemoglobin improves 21%, rises to 132g/L, no longer anaemia from 109g/L.
8, help to build healthy Bacillus acidi lactici group: feed the mouse of raising spirulina, in body, Bacillus acidi lactici content has increased by 3 times than control group.In mouse diet, add 5% spirulina, feed 100 days, result is: the weight of caecum increases by 13%, and Bacillus acidi lactici increases by 327%, and in caecum, vitamin B1 increases by 43%.Spirulina does not provide this extra vitamin B1, but has improved the absorption of whole vitamin B1.Illustrate that edible spirulina increases the Bacillus acidi lactici in body, and the efficiency that makes body absorb vitamin B1 and other vitamins from diet improves.
9, the protective effect to stomach: blunt top spirulina gavage 250-500mg/kg, has obvious protective effect to Indomethacin (indocin) type, absolute ethyl alcohol type experimental gastric ulcer model; Can reduce the incidence of pyloric ligation ulcers rat ulcer model and reduce ulcer number, gastric secretion is also had to certain inhibitory action; Can accelerate the healing of chronic acetic acid type rat gastric ulcer.
10, alleviate mercury and the medicine toxicity to kidney: after the high concentration organic mercury medicine preparing to mouse injection, the blood urea nitrogen (BUN) (BUN) that shows renal toxicity increases by 310%, serum creatine increases 198%, in diet, add after 30% spirulina, BUN declines 20%, serum creatine reduces by 157%, has 2 examples to be down to initial level.To mouse, using after common drug, also can observe similar phenomenon, as analgestic, antibiotic, anticarcinogen etc.
11, other effects: with the forage feed chicken containing blunt top spirulina, can make chicken body weight increase by 80%, this is to include the existence of iodine compound due to blunt top spirulina, as T4, T3, the growth that these have stimulated chicken containing iodine compound.In addition, spirulina can make blood sugar reduce, and suppresses increased blood pressure
The specific embodiment
Below in conjunction with a preferred embodiment, invention is further elaborated, following (with 1000 liters of finished products, raw materials by weight meter): a of technical scheme production craft step provided by the invention, spirulina 0.3%, white granulated sugar 10%, citric acid 0.08%, lactic acid 0.02%, vitamin C 0.02%, zinc gluconate 0.02%, sucrose ester 0.06%, disodium ethylene diamine tetraacetate 0.02%, β-carrotene 0.03%, lemon extract 0.06%, drinking water are standby; B, technological process: 1. spirulina leaching liquor is prepared in pretreatment; Spirulina is added to water 60kg, and mixing its pH of rear adjustment thoroughly is 11 left and right, separately prepares 2. 5% enzyme liquid, add people 2.5kg, and control temperature is 48-50 ℃, carries out the enzyme digestion reaction of 6-7h.Can add subsequently the color stabilizers such as disodium ethylene diamine tetraacetate to protect look, then spirulina liquid be entered to supercentrifuge, under 3500 revs/min of conditions, operate 15-20 minute, obtain its clear liquid; 2. allotment is first warded off white sand and is added l times of warm water and dissolve, then adds the solution of other raw materials of people, mixes, adds spirulina liquid again, starts agitator and stirs, and adds subsequently water and is settled to 1000 liters; 3. homogeneous, degassed by mixed liquor people high pressure homogenizer homogeneous, homogenization pressure is 25-3OMPa, removes the air in beverage immediately with vacuum degassing machine; 4. filling, sterilization is heated to 60-65 ℃ by beverage with plate type heat exchanger, is filled into while hot bottle, then in people's hot water, sterilization 15-20 minute at 100 ℃ of temperature, after cooling green transparent, sweet and sour palatability, the spirulina health-care beverage of tool taste of fruit.
The above, be only the specific embodiment of the present invention, but protection scope of the present invention is not limited to this, and any variation of expecting without creative work or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (1)
1. a spirulina health-care beverage, it is characterized in that, adopt following technical scheme (with 1000 liters of finished products, raw materials by weight meter): a, spirulina 0.2-0.3%, white granulated sugar 9-12%, citric acid 0.08%, lactic acid 0.02%, vitamin C 0.02%, zinc gluconate 0.02%, sucrose ester 0.06%, disodium ethylene diamine tetraacetate 0.02%, β-carrotene 0.03%, lemon extract 0.06%, drinking water are standby; B, technological process: 1. spirulina leaching liquor is prepared in pretreatment; Spirulina is added to water 60kg, mixing its pH of rear adjustment thoroughly is 11 left and right, another preparation 2. 5% enzyme liquid, add people 2.5kg, control temperature is 48-50 ℃, carries out the enzyme digestion reaction of 6-7h, can add subsequently the color stabilizers such as disodium ethylene diamine tetraacetate to protect look, then spirulina liquid is entered to supercentrifuge, under 3500 revs/min of conditions, operate 15-20 minute, obtain its clear liquid; 2. allotment is first warded off white sand and is added l times of warm water and dissolve, then adds the solution of other raw materials of people, mixes, adds spirulina liquid again, starts agitator and stirs, and adds subsequently water and is settled to 1000 liters; 3. homogeneous, degassed by mixed liquor people high pressure homogenizer homogeneous, homogenization pressure is 25-3OMPa, removes the air in beverage immediately with vacuum degassing machine; 4. filling, sterilization is heated to 60-65 ℃ by beverage with plate type heat exchanger, is filled into while hot bottle, then in people's hot water, sterilization 15-20 minute at 100 ℃ of temperature, after cooling green transparent, sweet and sour palatability, the spirulina health-care beverage of tool taste of fruit.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210387939.9A CN103719987A (en) | 2012-10-15 | 2012-10-15 | Spirulina health care drink |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210387939.9A CN103719987A (en) | 2012-10-15 | 2012-10-15 | Spirulina health care drink |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103719987A true CN103719987A (en) | 2014-04-16 |
Family
ID=50444481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210387939.9A Pending CN103719987A (en) | 2012-10-15 | 2012-10-15 | Spirulina health care drink |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103719987A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104522827A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment nutritional solid drink and preparation process thereof |
| CN106107374A (en) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | A kind of spirulina health-care beverage and preparation method thereof |
| CN111096400A (en) * | 2019-12-06 | 2020-05-05 | 嗨能天然饮料(广州)有限公司 | Spirulina health-care beverage |
| CN113575827A (en) * | 2021-07-01 | 2021-11-02 | 杭州娃哈哈科技有限公司 | Compound color fixative for carotenoid-containing fruit juice beverage and application thereof |
-
2012
- 2012-10-15 CN CN201210387939.9A patent/CN103719987A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104522827A (en) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | Alga ferment nutritional solid drink and preparation process thereof |
| CN106107374A (en) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | A kind of spirulina health-care beverage and preparation method thereof |
| CN111096400A (en) * | 2019-12-06 | 2020-05-05 | 嗨能天然饮料(广州)有限公司 | Spirulina health-care beverage |
| CN113575827A (en) * | 2021-07-01 | 2021-11-02 | 杭州娃哈哈科技有限公司 | Compound color fixative for carotenoid-containing fruit juice beverage and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102273680B (en) | Flammulina velutipes polysaccharide composite beverage and preparation method thereof | |
| CN1275534C (en) | Corn peptide beverage and its processing method | |
| CN106172250A (en) | A kind of mating system of Apis | |
| CN103103057A (en) | Preparation method of silkworm caterpillar fungus nutritive liqueur | |
| CN103725469A (en) | Health dry red wine | |
| CN101991165B (en) | Sweet potato leaf-perilla leaf composite beverage and preparation method thereof | |
| CN1860902A (en) | Sugar-free soft-sweets and hard-sweets made of spirulina for replenishing nutrient elements, and its prepn. method | |
| CN103719987A (en) | Spirulina health care drink | |
| WO2015124083A1 (en) | Beverage dissolved with phytosterol and production method therefor | |
| CN107007646A (en) | A kind of nutrition compound of assisting in preventing and treating cancer | |
| CN104686806A (en) | Compound feed additive for enhancing broiler chicken immunity | |
| CN103436419A (en) | Health care wine prepared from oysters and preparation method thereof | |
| CN107961260A (en) | Treatment, the medicament for preventing birds coliform diarrhea disease and preparation method thereof | |
| CN101961067A (en) | Novel feed additive for broilers | |
| CN101053437B (en) | Organic germanium Ge-132 glossy ganoderma beverage and processing method | |
| CN101589743A (en) | A kind of watermelon juice nutritious milk that contains prebiotics | |
| CN104509748A (en) | Chicken feed additive and preparation method thereof | |
| CN107897588A (en) | Black ginseng garlic drinks and preparation method thereof | |
| CN107502509A (en) | A kind of low alcohol content Raspberry health wine beverage and preparation method thereof | |
| CN107712875A (en) | Black quinoa weight losing meal-replacing | |
| CN103690962B (en) | A kind of dog independently searches for food type pharmaceutical carrier and preparation method thereof | |
| CN103828765B (en) | A kind of pseudo-classic chicken-raising method healthy, the most efficient | |
| CN105767997A (en) | Bee pollen and preparation method thereof | |
| CN101731591A (en) | Bee glue honeyed paste and preparation method | |
| CN104187658B (en) | Columba livia health care oral liquid and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140416 |